DEA claims cannabis holds no medicinal value even as the federal government owns the PATENT on its use as a medicine
by: L.J. Devon
NaturalNews.com
Tuesday, September 06, 2016
For decades, tetrahydrocannabinol (THC), of the herb cannabis sativa, has been at the top of the Drug Enforcement Agency (DEA) hit list. This targeted plant and its natural properties continue to be classified as a schedule one drug on the DEA’s senseless drug scheduling system. Cannabis is listed alongside meth and LSD for having “no currently accepted medical use and a high potential for abuse.” The DEA is adamant about controlling cannabis, even at a time when state governments are decriminalizing it altogether and allowing for its use in medical treatments.
DEA refuses to admit that cannabis has medicinal value, despite widespread evidence to the contrary
In August 2016, the DEA was expected to reclassify cannabis or remove it from their hit list altogether; however, when decision time arrived, the DEA refused to remove cannabis from its highly schedule one drug status. Even though cannabis has become a vital part of cancer treatments and an effective treatment for seizures, anxiety, and glaucoma, the DEA stated that “science doesn’t support” cannabis as useful for any medical purposes.
The Rest…HERE
